ArticleCancers2026

Impact of Blood Type and Administration Timing on Therapeutic Outcomes of Immune Checkpoint Inhibitors for Patients with Lung Cancer in the Chinese Alpine Region.

Meiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.